{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:03:29Z","timestamp":1740107009928,"version":"3.37.3"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2018,3,21]],"date-time":"2018-03-21T00:00:00Z","timestamp":1521590400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1007\/s00520-018-4165-6","type":"journal-article","created":{"date-parts":[[2018,3,21]],"date-time":"2018-03-21T08:35:23Z","timestamp":1521621323000},"page":"3055-3061","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Addition of doxycycline to ciprofloxacin for infection prophylaxis during autologous stem cell transplants for multiple myeloma"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3259-1584","authenticated-orcid":false,"given":"J. M.","family":"Sivik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. M.","family":"Hale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. J.","family":"Drabick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Talamo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,3,21]]},"reference":[{"key":"4165_CR1","doi-asserted-by":"publisher","first-page":"9219","DOI":"10.1200\/JCO.2005.03.2086","volume":"23","author":"BM Augustson","year":"2005","unstructured":"Augustson BM, Begum G, Dunn JA, Barth NJ, Davies F, Morgan G, Behrens J, Smith A, Child JA, Drayson MT (2005) Early mortality after diagnosis of multiple myeloma: analysis of patients entered onto the United Kingdom Medical Research Council trials between 1980 and 2002-Medical Research Council adult leukemia working party. J Clin Oncol 23:9219\u20139226","journal-title":"J Clin Oncol"},{"key":"4165_CR2","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1086\/605664","volume":"49","author":"M Nucci","year":"2009","unstructured":"Nucci M, Anaissie E (2009) Infections in patients with multiple myeloma in the era of high-dose therapy and novel agents. Clin Infect Dis 49:1211\u20131225","journal-title":"Clin Infect Dis"},{"key":"4165_CR3","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1111\/bjh.13532","volume":"171","author":"BW Teh","year":"2015","unstructured":"Teh BW, Harrison SJ, Worth LJ, Spelman T, Thursky KA, Slavin MA (2015) Risks, severity and timing of infections with multiple myeloma: a longitudinal cohort study in the era of immunomodulatory drug therapy. Br J Haematol 171:100\u2013108","journal-title":"Br J Haematol"},{"key":"4165_CR4","doi-asserted-by":"publisher","first-page":"234","DOI":"10.4274\/tjh.2013.0173","volume":"32","author":"T Valkovic","year":"2015","unstructured":"Valkovic T, Gacic V, Ivandic J, Petrov B, Dobrila-Dintinjana R et al (2015) Infections in hospitalized patients with multiple myeloma: main characteristics and risk factors. Turk J Hematol 32:234\u2013242","journal-title":"Turk J Hematol"},{"key":"4165_CR5","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1056\/NEJMoa1402888","volume":"371","author":"A Palumbo","year":"2014","unstructured":"Palumbo A, Cavallo F, Gay F, Di Raimondo F, Yehuda DB, Petrucci MT et al (2014) Autologous transplantation and maintenance therapy in multiple myeloma. New Engl J Med 371:895\u2013905","journal-title":"New Engl J Med"},{"key":"4165_CR6","first-page":"719","volume":"14","author":"PM Voorhees","year":"2016","unstructured":"Voorhees PM, Usmani SZ (2016) The role of high-dose melphalan and autologous stem cell transplant in the rapidly evolving era of modern multiple myeloma therapy. Clin Adv Hematol Oncol 14:719\u2013728","journal-title":"Clin Adv Hematol Oncol"},{"key":"4165_CR7","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1055\/s-2006-945530","volume":"27","author":"B Afessa","year":"2006","unstructured":"Afessa B, Peters SG (2006) Major complications following hematopoietic stem cell transplantation. Semin Respir Crit Care Med 27:297\u2013309","journal-title":"Semin Respir Crit Care Med"},{"key":"4165_CR8","doi-asserted-by":"publisher","first-page":"18","DOI":"10.2174\/187152611794407764","volume":"11","author":"CE Magauran","year":"2011","unstructured":"Magauran CE, Salgado CD (2011) Challenges and advances in infection control of hematopoietic stem cell transplant recipients. Infect Disord Drug Targets 11:18\u201326","journal-title":"Infect Disord Drug Targets"},{"key":"4165_CR9","first-page":"337","volume":"10","author":"MB Salzman","year":"1995","unstructured":"Salzman MB, Rubin LG (1995) Intravenous catheter-related infections. Adv Pediatr Infect Dis 10:337\u2013368","journal-title":"Adv Pediatr Infect Dis"},{"key":"4165_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1086\/599376","volume":"49","author":"LA Mermel","year":"2009","unstructured":"Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O\u2019Grady NP, Raad II, Rijnders BJA, Sherertz RJ, Warren DK (2009) Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 updates by the Infectious Diseases Society of America. Clin Infect Dis 49:1\u201345","journal-title":"Clin Infect Dis"},{"key":"4165_CR11","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1016\/j.bbmt.2015.06.017","volume":"21","author":"MJ Satlin","year":"2015","unstructured":"Satlin MJ, Vardhana S, Soave R, Shore TB, Mark TM, Jacobs SE, Walsh TJ, Gergis U (2015) Impact of prophylactic levofloxacin on rates of bloodstream infection and fever in neutropenic patients with multiple myeloma undergoing autologous hematopoietic stem cell transplantation. BIol Blood Marrow Transplant 21:1808\u20131814","journal-title":"BIol Blood Marrow Transplant"},{"key":"4165_CR12","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/bmt.2014.56","volume":"49","author":"SR Parmar","year":"2014","unstructured":"Parmar SR, Bookout R, Shapiro JF, Tombleson R, Perkins J, Kim J, Yue B, Tomblyn M, Alsina M, Nishihori T (2014) Comparison of 1-day vs 2-day dosing of high dose melphalan followed by autologous hematopoietic cell transplantation in patients with multiple myeloma. Bone Marrow Transplant 49:761\u2013766","journal-title":"Bone Marrow Transplant"},{"key":"4165_CR13","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/bmt.2014.226","volume":"50","author":"R St Bernard","year":"2015","unstructured":"St Bernard R, Chodirker L, Masih-Khan E, Jiang H, Franke N, Kukreti V, Tiedemann R, Trudel S, Reece D, Chen CI (2015) Efficacy, toxicity and mortality of autologous SCT in multiple myeloma patients with dialysis-dependent renal failure. Bone Marrow Transplant 50:95\u201399","journal-title":"Bone Marrow Transplant"},{"key":"4165_CR14","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1056\/NEJMoa044097","volume":"353","author":"G Bucaneve","year":"2005","unstructured":"Bucaneve G, Micozzi A, Menichetti F, Martino P, Dionisi MS, Martinelli G, Allione B, D\u2019Antonio D, Buelli M, Nosari AM, Cilloni D, Zuffa E, Cantaffa R, Specchia G, Amadori S, Fabbiano F, Deliliers GL, Lauria F, Fo\u00e0 R, del Favero A, Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) Infection Program (2005) Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia. New Engl J Med. 353:977\u2013987","journal-title":"New Engl J Med."},{"key":"4165_CR15","doi-asserted-by":"publisher","first-page":"979","DOI":"10.7326\/0003-4819-142-12_Part_1-200506210-00008","volume":"142","author":"A Gafter-Gvili","year":"2005","unstructured":"Gafter-Gvili A, Fraser A, Paul M, Leibovici L (2005) Meta-analysis: antibiotic prophylaxis reduces mortality in neutropenic patients. Ann Intern Med 142:979\u2013995","journal-title":"Ann Intern Med"},{"issue":"4","key":"4165_CR16","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1093\/cid\/cir073","volume":"52","author":"AG Freifield","year":"2011","unstructured":"Freifield AG, Bow EJ, Sepkowicz KA, Boeckh MJ, Ito JI, Mullen CA et al (2011) Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 52(4):e56\u2013e93","journal-title":"Clin Infect Dis"},{"key":"4165_CR17","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1186\/1471-2334-13-284","volume":"13","author":"L Saini","year":"2013","unstructured":"Saini L, Rostein C, Atenafu EG, Brandwein JM (2013) Ambulatory consolidation chemotherapy for acute myeloid leukemia with antibacterial prophylaxis is associated with frequent bacteremia and the emergence of fluoroquinolone resistant E. coli. BMC Infect Dis 13:284","journal-title":"BMC Infect Dis"},{"issue":"1","key":"4165_CR18","doi-asserted-by":"publisher","first-page":"e2013015","DOI":"10.4084\/mjhid.2013.015","volume":"5","author":"M Baydoun","year":"2013","unstructured":"Baydoun M, Otrock ZK, Okaily S, Nehme R, Abu-Chahine R, Hamdan A, Noureddine S, Kanj S, Kanafani Z, Bazarbachi A, Kharfan-Dabaja MA (2013) Prophylactic administration of doxycycline reduces central venous catheter infections in patients undergoing hematopoietic cell transplantation. Mediterr J Hematol Infect Dis 5(1):e2013015","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"4165_CR19","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/bmt.2008.446","volume":"44","author":"G Talamo","year":"2009","unstructured":"Talamo G, Claxton DF, Dougherty DW, Ehmann CW, Sivik J, Drabick JJ, Rybka W (2009) BU and CY as conditioning regimen for autologous transplant in patients with multiple myeloma. Bone Marrow Transplant 44:157\u2013161","journal-title":"Bone Marrow Transplant"},{"key":"4165_CR20","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/j.1600-0609.2012.01795.x","volume":"89","author":"G Talamo","year":"2012","unstructured":"Talamo G, Rakszawski KL, Rybka WB, Dolloff NG, Malysz J, Berno T, Zangari M (2012) Effect of time to infusion of autologous stem cells (24 vs 48 h) after high-dose melphalan in patients with multiple myeloma. Eur J Hematol 89:145\u2013150","journal-title":"Eur J Hematol"},{"key":"4165_CR21","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.clml.2015.05.008","volume":"15","author":"M Veeraputhiran","year":"2015","unstructured":"Veeraputhiran M, Jain T, Deol A, Ayash L, Kim S, Dyson G, Bhutani D, Lum LG, Ratanatharathorn V, Uberti JP, Abidi MH (2015) BEAM conditioning regimen has higher toxicity compared with high-dose melphalan for salvage autologous hematopoietic stem cell transplantation in multiple myeloma. Clin Lymphoma Myeloma Leuk 15:531\u2013535","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"4165_CR22","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1200\/JCO.1995.13.3.588","volume":"13","author":"W Mills","year":"1995","unstructured":"Mills W, Chopra R, McMillan A, Pearce R, Linch DC, Goldstone AH (1995) BEAM chemotherapy and autologous bone marrow transplantation for patients with relapsed or refractory non-Hodgkin\u2019s lymphoma. J Clin Oncol 13:588\u2013595","journal-title":"J Clin Oncol"},{"key":"4165_CR23","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1038\/sj.leu.2404284","volume":"20","author":"BG Durie","year":"2006","unstructured":"Durie BG, Harousseau JL, Miguel JS, Blade J, Barlogie B, Anderson K et al (2006) International uniform response criteria for multiple myeloma. Leukemia 20:1467\u20131473","journal-title":"Leukemia"},{"key":"4165_CR24","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/sj.bmt.1704423","volume":"33","author":"S Trifilo","year":"2004","unstructured":"Trifilo S, Verma A, Mehta J (2004) Antimicrobial prophylaxis in hematopoietic stem cell transplant recipients: heterogeneity of current clinical practice. Bone Marrow Transplant 33:735\u2013739","journal-title":"Bone Marrow Transplant"},{"key":"4165_CR25","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1086\/428732","volume":"40","author":"S Reuter","year":"2005","unstructured":"Reuter S, Kern WV, Sigge A, Dohner H, Marre R, Kern P, von Baum H (2005) Impact of fluoroquinolone prophylaxis on reduced infection-related mortality among patients with neutropenia and hematologic malignancies. Clin Infect Dis 40:1087\u20131093","journal-title":"Clin Infect Dis"},{"key":"4165_CR26","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1345\/aph.1R439","volume":"46","author":"JR Wong","year":"2012","unstructured":"Wong JR, Bauer KA, Mangino JE, Goff DA (2012) Antimicrobial stewardship pharmacist interventions for coagulase-negative staphylococci positive blood cultures using rapid polymerase chain reaction. Ann Pharmacother 46:1484\u20131490","journal-title":"Ann Pharmacother"},{"key":"4165_CR27","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1056\/NEJMoa1113849","volume":"368","author":"MW Climo","year":"2013","unstructured":"Climo MW, Yokoe DS, Warren DK, Perl TM, Bolon M, Herwaldt LA, Weinstein RA, Sepkowitz KA, Jernigan JA, Sanogo K, Wong ES (2013) Effect of daily chlorhexidine bathing on hospital-acquired infection. New Engl J Med. 368:533\u2013542","journal-title":"New Engl J Med."},{"key":"4165_CR28","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1093\/cid\/cis457","volume":"55","author":"SB Doernberg","year":"2012","unstructured":"Doernberg SB, Winston LG, Deck DH, Chambers HF (2012) Does doxycycline protect against development of Clostridium difficile infection? Clin Infect Dis 55:615\u2013620","journal-title":"Clin Infect Dis"},{"key":"4165_CR29","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1093\/jac\/dkt129","volume":"68","author":"A Deshpande","year":"2013","unstructured":"Deshpande A, Pasupuleti V, Thota P, Pant C, Rolston DD, Sferra TJ, Hernandez AV (2013) Donskey CJ. Community-associated Clostridium difficile infection and antibiotics: a meta-analysis. J Antimicrob Chemother 68:1951\u20131961","journal-title":"J Antimicrob Chemother"},{"key":"4165_CR30","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1093\/cid\/cix833","volume":"66","author":"R Tariq","year":"2018","unstructured":"Tariq R, Cho J, Kapoor S, Orenstein R, Singh S, Pardi DS, Khanna S (2018) Low risk of primary Clostridium difficile infection with tetracyclines: a systematic review and metaanalysis. Clin Infect Dis 66:514\u2013522","journal-title":"Clin Infect Dis"},{"key":"4165_CR31","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1182\/blood.V98.7.2059","volume":"98","author":"U Narayanasami","year":"2001","unstructured":"Narayanasami U, Kanteti R, Morelli J, Klekar A, Al-Olama A, Keating C et al (2001) Randomized trial of filgrastim versus chemotherapy and filgrastim mobilization of hematopoietic progenitor cells for rescue in autologous transplantation. Blood 98:2059\u20132064","journal-title":"Blood"},{"key":"4165_CR32","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1007\/s12185-017-2313-2","volume":"106","author":"H Park","year":"2017","unstructured":"Park H, Youk J, Kim HR, Koh Y, Kwon JH, Yoon SS, Park S, Choe PG, Kim NJ, Oh MD, Park WB, Kim I (2017) Infectious complications in multiple myeloma receiving autologous stem cell transplantation in the past 10 years. Int J Hematol 106:801\u2013810. \n                    https:\/\/doi.org\/10.1007\/s12185-017-2313-2","journal-title":"Int J Hematol"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-018-4165-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-018-4165-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-018-4165-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,20]],"date-time":"2019-03-20T20:26:45Z","timestamp":1553113605000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-018-4165-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,21]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["4165"],"URL":"https:\/\/doi.org\/10.1007\/s00520-018-4165-6","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"type":"print","value":"0941-4355"},{"type":"electronic","value":"1433-7339"}],"subject":[],"published":{"date-parts":[[2018,3,21]]},"assertion":[{"value":"8 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}